The McDougall Program - A Game-Changer Against Semaglutide in Weight Loss! [liNcftC3sWF]

The McDougall Program - A Game-Changer Against Semaglutide in Weight Loss! [liNcftC3sWF]

| 1h 28m 28s | Video has closed captioning.

Explore the McDougall Program's battle against semaglutide in a quest for superior health and weight loss. Dr. John McDougall champions the starch-based diet, showcasing its benefits over semaglutide injections for weight loss. This discussion highlights the starch-based diet's ability to enhance health, reduce costs, and protect the environment, contrasting with semaglutide's high expenses and side effects. The McDougall Program vs semaglutide comparison reveals the natural diet's advantage in mitigating diseases like hypertension and diabetes without the negative impacts of semaglutide weight loss methods. 0:00 - Dr McDougall on Semaglutide vs McDougall Program 4:01 - Health Risks of Weight Loss Drugs 9:05 - Weight Loss Drugs Affecting Your Sex Life? 10:06 - Commonalitiles in McDougall Program & Semaglutides 11:26 - Dietary Impact on Health Conditions 12:51 - Do We All Have Hemorrhoids? 21:08 - Is This Going to Help With Climate Change? 25:20 - Is TSA of 2.7 Worrisome? 28:10 - Too much Strain & Diverticulitis 31:21 - Colon Screening & Diet? 40:00 - Avascular necrosis & More! 44:05 - Avoiding Surgery in Hernia 49:37 - Dumping Syndrome & What Can Help? 55:03 - Bleeding Ulcers in Late 20s! 58:38 - Outro & Next in McDougall Program Alcohol mortality CHD, BP: Zhao J, Stockwell T, Naimi T, Churchill S, Clay J, Sherk A. Association Between Daily Alcohol Intake and Risk of All-Cause Mortality: A Systematic Review and Meta-analyses. JAMA Netw Open. 2023 Mar 1;6(3):e236185. doi: 10.1001/jamanetworkopen.2023.6185. Erratum in: JAMA Netw Open. 2023 May 1;6(5):e2315283. PMID: 37000449; PMCID: PMC10066463. Biddinger KJ, Emdin CA, Haas ME, Wang M, Hindy G, Ellinor PT, Kathiresan S, Khera AV, Aragam KG. Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease. JAMA Netw Open. 2022 Mar 1;5(3):e223849. doi: 10.1001/jamanetworkopen.2022.3849. Erratum in: JAMA Netw Open. 2022 Apr 1;5(4):e2212024. PMID: 35333364; PMCID: PMC8956974. Di Federico S, Filippini T, Whelton PK, Cecchini M, Iamandii I, Boriani G, Vinceti M. Alcohol Intake and Blood Pressure Levels: A Dose-Response Meta-Analysis of Nonexperimental Cohort Studies. Hypertension. 2023 Oct;80(10):1961-1969. doi: 10.1161/HYPERTENSIONAHA.123.21224. Epub 2023 Jul 31. PMID: 37522179; PMCID: PMC10510850. References skin cancer: Mahamat-Saleh Y, Cervenka I, Al Rahmoun M, Savoye I, Mancini FR, Trichopoulou A, Boutron-Ruault MC, Kvaskoff M. Mediterranean dietary pattern and skin cancer risk: A prospective cohort study in French women. Am J Clin Nutr. 2019 Oct 1;110(4):993-1002. doi: 10.1093/ajcn/nqz173. PMID: 31380561. References pregnancy: Makarem N, Chau K, Miller EC, Gyamfi-Bannerman C, Tous I, Booker W, Catov JM, Haas DM, Grobman WA, Levine LD, McNeil R, Bairey Merz CN, Reddy U, Wapner RJ, Wong MS, Bello NA. Association of a Mediterranean Diet Pattern With Adverse Pregnancy Outcomes Among US Women. JAMA Netw Open. 2022 Dec 1;5(12):e2248165. doi: 10.1001/jamanetworkopen.2022.48165. PMID: 36547978; PMCID: PMC9857221. Reference - Delivery systems for semaglutides: Alhiary R?, Kesselheim AS?, Gabriele S?, Beall RF?, Tu SS?, Feldman WB?. Patents and regulatory exclusivities on GLP-1 receptor agonists. ? JAMA. 2023;330(7):650-657. doi:10.1001/jama.2023.13872 References adherence: Gasoyan H, Pfoh ER, Schulte R, Le P, Rothberg MB. Early- and later-stage persistence with antiobesity medications: A retrospective cohort study. Obesity (Silver Spring). 2023 Dec 6. doi: 10.1002/oby.23952. Epub ahead of print. PMID: 38053443. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331(1):38–48. A total of 81.0% of participants reported at least 1 treatment-emergent adverse event during the tirzepatide lead-in treatment period, with the most frequent events being gastrointestinal (nausea [35.5%], diarrhea, [21.1%], constipation [20.7%], and vomiting [16.3%]; 👉 Subscribe to our YouTube Channel to Transform Your Health: @themcdougallprogram 👉Learn more about The Dr. McDougall Health & Medical Center: 👉 Join the 12-Day McDougall Program - A life-saving online medical program for over 35 years, reversing and healing chronic illness through expert care, education, and whole food, starch-based nutrition: 👉 For a wealth of free information, visit our website, where you'll find a treasure trove of resources: We're here to assist you! Feel free to reach out to us at [email protected]. #proburn keto acv gummies #highest rated otc diet pills #keto friendly gummies